Peer-reviewed veterinary case report
Accuracy of flash glucose monitoring in dogs with diabetic
By Silva, D D et al.·Published in Domestic animal endocrinology·2021·Department of Veterinary Clinics, Brazil·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Evaluation of a flash glucose monitoring system in dogs with diabetic ketoacidosis.
- Species:
- dog
Plain-English summary
A group of seven dogs diagnosed with diabetic ketoacidosis (DKA) were monitored using a flash glucose monitoring system (FGMS) to track their blood sugar levels. The sensor was placed under the skin and provided continuous glucose readings, which were compared to traditional blood glucose measurements taken every few hours. While the FGMS showed good accuracy overall, it was less precise in dogs with low blood sugar levels. Despite not meeting all industry standards, the FGMS proved to be a helpful tool for managing blood glucose in dogs with DKA, aiding in their treatment and recovery.
People also search for: dog diabetic ketoacidosis treatment · flash glucose monitor for dogs · managing dog blood sugar levels
Abstract
The flash glucose monitoring system (FGMS) Freestyle Libre provides estimates of blood glucose by constantly measuring the glucose concentration of the interstitial fluid through a sensor inserted in the subcutaneous space. The aim of this study was to evaluate the applicability and accuracy of the FGMS in dogs with diabetic ketoacidosis (DKA). Seven dogs with DKA examined at the Veterinary Hospital of the State University of Londrina were included in this study. The sensor was placed on the dorsal cervical region, shortly after the diagnosis of DKA was confirmed and maintained for 5 d. The measurement of blood glucose was performed simultaneously with the veterinary portable blood glucose meter (PBGM) AlphaTRAK 2 every 2 to 4 h and with the hexokinase method every 12 h. The PBGM's precision was evaluated following the ISO15197:2013 criteria. Blood glucose estimates were strongly associated (r = 0.89; P < 0.0001), and the mean absolute relative difference in relation to the PBGM was 25.2% (-70.4% to 101.9%). The evaluation of these data using the consensus error grid analysis showed that 95.4% and 94.8% of the samples were in Zones A and B (clinically acceptable) using the PBGM and the hexokinase method as a reference, respectively. The ISO15197:2013 criteria were not met. There was no difference in the accuracy of the device among days (P = 0.74); however, there was a difference between the hydration status (P = 0.019) and blood glucose ranges (hypoglycemic, euglycemic, and hyperglycemic; P < 0.0001), in which it was less precise in measuring the blood glucose range in hypoglycemic dogs. Therefore, it can be concluded that in spite of the fact that the device did not meet the ISO 15197:2013 criteria, the FGMS evaluated presents good clinical precision and can be a valuable tool in treating dogs with diabetic DKA.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/32799040/